Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell-surface α2,3- and α2,6-linked sialic acid residues are terminal monosaccharides found on the glycan chains of glycoproteins and glycolipids. These residues play a critical role in biological recognition, serving as essential receptors for various pathogens, most notably the influenza virus, where α2,3-linkages are preferred by avian strains and α2,6-linkages by human strains (Long et al., 2019). In the context of oncology, many tumors exhibit hypersialylation, a process where an overabundance of these residues creates a "glycan shield" that interacts with Siglec receptors on immune cells to suppress the anti-tumor immune response (Läubli & Varki, 2020). Therapeutic strategies targeting these residues include the use of neuraminidase inhibitors to block viral egress and engineered sialidases, such as E-602, to strip these residues from the surface of cancer cells, thereby enhancing immune detection (Palleon Pharmaceuticals, 2023). Additionally, these residues are involved in cell-cell adhesion and inflammatory signaling pathways (Varki, 2008). Understanding the distribution and linkage types of these sialic acids is vital for developing targeted anti-infectives and next-generation cancer immunotherapies.
Enzymatic removal of sialic acid residues (desialylation) to prevent pathogen entry or disrupt immune-suppressive Siglec signaling; competitive inhibition of viral neuraminidase to prevent the release of viral progeny from sialylated host cell surfaces.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell-surface α2,3- and α2,6-linked sialic acid residues (α2,3/α2,6-Sia).